Beatrice Garrone

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Behavioral benefits of GSK-3β inhibition and state-dependent microtubule signatures in the Fmr1-KO mouse.

Behavioral benefits of GSK-3β inhibition and state-dependent microtubule signatures in the Fmr1-KO mouse.

Journal: Frontiers in neuroscience
Published: June 08, 2025

Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome.

Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome.

Journal: Neurobiology of disease
Published: June 07, 2024

PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development.

PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development.

Journal: Clinical and translational science
Published: September 20, 2022

Presynaptic 5-HT2A-mGlu2/3 Receptor-Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis.

Presynaptic 5-HT2A-mGlu2/3 Receptor-Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis.

Journal: Cells
Published: August 19, 2022

Testing Fmr1 KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127.

Testing Fmr1 KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127.

Journal: Frontiers in molecular neuroscience
Published: July 31, 2021

The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype.

The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype.

Journal: Human molecular genetics
Published: May 23, 2021

Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats.

Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats.

Journal: Scientific reports
Published: December 07, 2020

Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain.

Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain.

Journal: PloS one
Published: June 12, 2020

Acute Low Dose of Trazodone Recovers Glutamate Release Efficiency and mGlu2/3 Autoreceptor Impairments in the Spinal Cord of Rats Suffering From Chronic Sciatic Ligation.

Acute Low Dose of Trazodone Recovers Glutamate Release Efficiency and mGlu2/3 Autoreceptor Impairments in the Spinal Cord of Rats Suffering From Chronic Sciatic Ligation.

Journal: Frontiers in pharmacology
Published: May 14, 2020

Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo.

Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo.

Journal: Frontiers in pharmacology
Published: January 23, 2020

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 22, 2020

Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model.

Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model.

Journal: ACS medicinal chemistry letters
Published: December 20, 2019
Showing 1-12 of 17

Last Updated: 09/26/2026